Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation
Masao Ogata(Oita University), Hisako Hashimoto(Foundation for Biomedical Research and Innovation), Tadakazu Kondo(Kyoto University Hospital), Tatsuo Ichinohe(Hiroshima University), Kuniko Takano(Oita University), Yoshiko Atsuta(The Japanese Data Center for Hematopoietic Cell Transplantation), Takehiko Mori(Keio University), Heiwa Kanamori(Kanagawa Prefectural Hospital Organization), Toshihiro Miyamoto(Kyushu University), Taichi Ikebe(Oita University), Tetsuya Eto(Hamanomachi Hospital), Hiroyasu Ogawa(Hyogo Medical University), Tomoyuki Ueki(Nagano Red Cross Hospital), Yasunori Ueda(Kurashiki Central Hospital), Kiyohiro Oshima(Hiroshima University), Takahiro Fukuda(Takarazuka City Hospital)
Cited by 119
Related Papers
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435
One million haemopoietic stem-cell transplants: a retrospective observational study
|The Lancet Haematology|2015|434
Chromosomally integrated human herpesvirus 6: questions and answers
|Reviews in Medical Virology|2011|378
Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation
|Biology of Blood and Marrow Transplantation|2011|363
Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)
|International Journal of Hematology|2015|352